GAMMA Investing’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.6K Buy
1,910
+251
+15% +$2.46K ﹤0.01% 2801
2026
Q1
$10.5K Buy
1,659
+642
+63% +$5.78K ﹤0.01% 3052
2025
Q4
$10.9K Sell
1,017
-210
-17% -$2.31K ﹤0.01% 2937
2025
Q3
$15.3K Sell
1,227
-13
-1% -$133 ﹤0.01% 2661
2025
Q2
$12.7K Sell
1,240
-1,700
-58% -$15K ﹤0.01% 2689
2025
Q1
$23.2K Buy
2,940
+2,682
+1,040% +$33K ﹤0.01% 2299
2024
Q4
$2.02K Buy
+258
New +$1.29K ﹤0.01% 3216
2024
Q3
Sell
-486
Closed -$1.38K 3603
2024
Q2
$1.38K Sell
486
-194
-29% -$1.38K ﹤0.01% 2985
2024
Q1
$10.7K Sell
680
-2
-0.3% -$34 ﹤0.01% 2022
2023
Q4
$13.7K Buy
+682
New +$11.8K ﹤0.01% 1724

Other funds holding CRNC

GAMMA Investing's CRNC Position: Q2 2026 in Review

GAMMA Investing increased its Cerence (CRNC) stake by 15% in Q2 2026, buying an estimated $2.46K and bringing the position to 1,910 shares worth $21.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2801.

GAMMA Investing first reported a position in CRNC in Q4 2023 and has held it in 10 quarters since. The position peaked at $23.2K in Q1 2025. 22 funds tracked by Wall St. Rank hold CRNC as of Q2 2026.

  • GAMMA Investing held 1,910 shares of Cerence worth $21.6K as of Q2 2026.
  • GAMMA Investing bought 251 Cerence shares in Q2 2026, an estimated $2.46K.
  • Cerence made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2801 holding.
  • GAMMA Investing first reported a position in Cerence in Q4 2023 and has held it in 10 quarters since.
  • GAMMA Investing's Cerence position peaked at $23.2K in Q1 2025.
  • 22 funds tracked by Wall St. Rank held Cerence as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.